TY - JOUR
T1 - A terpene nucleoside from M. tuberculosis induces lysosomal lipid storage in foamy macrophages
AU - Bedard, Melissa
AU - van der Niet, Sanne
AU - Bernard, Elliott M.
AU - Babunovic, Gregory
AU - Cheng, Tan-Yun
AU - Aylan, Beren
AU - Grootemaat, Anita E.
AU - Raman, Sahadevan
AU - Botella, Laure
AU - Ishikawa, Eri
AU - O'Sullivan, Mary P.
AU - O'Leary, Seónadh
AU - Mayfield, Jacob A.
AU - Buter, Jeffrey
AU - Minnaard, Adriaan J.
AU - Fortune, Sarah M.
AU - Murphy, Leon O.
AU - Ory, Daniel S.
AU - Keane, Joseph
AU - Yamasaki, Sho
AU - Gutierrez, Maximiliano G.
AU - van der Wel, Nicole
AU - Moody, D. Branch
N1 - Funding Information: This work was supported by The Royal City of Dublin Hospital Trust (to JK), the Tuberculosis Research Unit Network (AI162584 and AI165573, to DBM; AI123286 and P01AI132130, to SAF), the Cancer Research United Kingdom (CRUK) (FC001092), the UK Medical Research Council (FC001092), and the Wellcome Trust (FC001092, to MGG). Publisher Copyright: © 2023, Bedard et al.
PY - 2023/3/15
Y1 - 2023/3/15
N2 - Induction of lipid-laden foamy macrophages is a cellular hallmark of tuberculosis (TB) disease, which involves the transformation of infected phagolysosomes from a site of killing into a nutrient-rich replicative niche. Here, we show that a terpenyl nucleoside shed from Mycobacterium tuberculosis, 1-tuberculosinyladenosine (1-TbAd), caused lysosomal maturation arrest and autophagy blockade, leading to lipid storage in M1 macrophages. Pure 1-TbAd, or infection with terpenyl nucleoside-producing M. tuberculosis, caused intralysosomal and peribacillary lipid storage patterns that matched both the molecules and subcellular locations known in foamy macrophages. Lipidomics showed that 1-TbAd induced storage of triacylglycerides and cholesterylesters and that 1-TbAd increased M. tuberculosis growth under conditions of restricted lipid access in macrophages. Furthermore, lipidomics identified 1-TbAd-induced lipid substrates that define Gaucher's disease, Wolman's disease, and other inborn lysosomal storage diseases. These data identify genetic and molecular causes of M. tuberculosis-induced lysosomal failure, leading to successful testing of an agonist of TRPML1 calcium channels that reverses lipid storage in cells. These data establish the host-directed cellular functions of an orphan effector molecule that promotes survival in macrophages, providing both an upstream cause and detailed picture of lysosome failure in foamy macrophages.
AB - Induction of lipid-laden foamy macrophages is a cellular hallmark of tuberculosis (TB) disease, which involves the transformation of infected phagolysosomes from a site of killing into a nutrient-rich replicative niche. Here, we show that a terpenyl nucleoside shed from Mycobacterium tuberculosis, 1-tuberculosinyladenosine (1-TbAd), caused lysosomal maturation arrest and autophagy blockade, leading to lipid storage in M1 macrophages. Pure 1-TbAd, or infection with terpenyl nucleoside-producing M. tuberculosis, caused intralysosomal and peribacillary lipid storage patterns that matched both the molecules and subcellular locations known in foamy macrophages. Lipidomics showed that 1-TbAd induced storage of triacylglycerides and cholesterylesters and that 1-TbAd increased M. tuberculosis growth under conditions of restricted lipid access in macrophages. Furthermore, lipidomics identified 1-TbAd-induced lipid substrates that define Gaucher's disease, Wolman's disease, and other inborn lysosomal storage diseases. These data identify genetic and molecular causes of M. tuberculosis-induced lysosomal failure, leading to successful testing of an agonist of TRPML1 calcium channels that reverses lipid storage in cells. These data establish the host-directed cellular functions of an orphan effector molecule that promotes survival in macrophages, providing both an upstream cause and detailed picture of lysosome failure in foamy macrophages.
UR - http://www.scopus.com/inward/record.url?scp=85150038374&partnerID=8YFLogxK
U2 - https://doi.org/10.1172/JCI161944
DO - https://doi.org/10.1172/JCI161944
M3 - Article
C2 - 36757797
SN - 0021-9738
VL - 133
JO - Journal of clinical investigation
JF - Journal of clinical investigation
IS - 6
M1 - e161944
ER -